Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection

Clinical trial NCT01067131 · COMPLETED

Trial details

NCT number: NCT01067131
Sponsor: Pevion Biotech Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Vulvovaginal Candidiasis

Start date: 2010-03-01
Primary completion: 2012-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.